Novartis, India Clash Over Patent Laws Wall Street Journal The Indian Patent Office order granting a compulsory license to Natco stated that 23,120 kidney- and liver-cancer patients would benefit from treatment using Nexavar, but in 2009 only 200 bottles were imported to India. A spokesman for Bayer wasn't ... |
